Comparison of the effects of botulinum toxin type A hamstring muscle injection combined with periarticular injection and simple periarticular injection on early pain and functional recovery after total knee arthroplasty
Objective: This study was designed to compare the effects of hamstring muscle injection of botulinum toxin type A (BoNT/A) combined with periarticular injection to those of simple periarticular injection alone, in terms of early pain reduction and functional recovery following total knee arthroplasty (TKA).
Methods: This study included 40 patients who underwent elective unilateral TKA at our hospital from February 2021 to December 2021. The patients were randomly assigned to either the experimental group (BoNT/A injection into the hamstring muscle + periarticular injection, n = 20 cases) or the control group (0.9% normal saline injection into the hamstring muscle + periarticular injection, n = 20 cases). The preoperative and postoperative 3-day HSS scores were compared between the two groups. Postoperative visual analog scale (VAS) pain scores were observed and compared between the two groups. The Lovett grading method was used to evaluate the postoperative muscle strength of both groups. Additionally, postoperative knee joint pain scores, maximum active flexion angle, and any postoperative adverse reactions were observed and compared between the two groups.
Results: The experimental group showed significantly lower VAS pain scores than the control group at 24 h, 48 h, and 72 h after the operation, with a statistically significant difference (P < 0.05). Furthermore, compared to the control group, the patients in the experimental group exhibited larger knee joint active flexion angles at 1 day, 3 days, and 5 days post-operation, also demonstrating a statistically significant difference (P < 0.05). These findings hold scientific significance (P < 0.05). Additionally, the combined administration of BoNT/A hamstring muscle injection with periarticular injection exhibited a low incidence of adverse reactions during the perioperative period and had no significant effect on quadriceps muscle strength.
Conclusion: The combination of BoNT/A hamstring muscle injection with periarticular injection effectively alleviates early postoperative pain following TKA and promotes early functional recovery of the knee joint.
Cui A, Li H, Wang D, Zhong J, Chen Y, Lu H. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. eClinicalMedicine 2020; 29–30: 100587. doi: 10.1016/j.eclinm.2020.100587
Zeng CY, Zhang ZR, Tang ZM, Hua FZ. Benefits and mechanisms of exercise training for knee osteoarthritis. Front Physiol 2021; 12: 794062. doi: 10.3389/fphys.2021.794062
Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis: a review. J Am Med Assoc 2021; 325(6): 568–78. doi: 10.1001/jama.2020.22171
Saeedi T, Alotaibi HF, Prokopovich P. Polymer colloids as drug delivery systems for the treatment of arthritis. Adv Colloid Interface Sci 2020; 285: 102273. doi: 10.1016/j.cis.2020.102273
American Society of Anesthesiologists Task Force on Acute Pain M. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology 2012; 116(2): 248–73.
Chung AS, Spangehl MJ. Peripheral nerve blocks vs Periarticular injections in total knee arthroplasty. J Arthroplasty 2018; 33(11): 3383–8. doi: 10.1016/j.arth.2018.08.006
Brodsky MA, Swope DM, Grimes D. Diffusion of botulinum toxins. Tremor Other Hyperkinet Mov (N Y) 2012; 2: tre-02-85-417-1. doi: 10.7916/D88W3C1M
Rojewska E, Piotrowska A, Popiolek-Barczyk K, Mika J. Botulinum toxin type A-A modulator of spinal neuron-glia interactions under neuropathic pain conditions. Toxins (Basel) 2018; 10(4): 145. doi: 10.3390/toxins10040145
Manuel Munoz-Lora VR, Abdalla HB, Del Bel Cury AA, Clemente-Napimoga JT. Modulatory effect of botulinum toxin type A on the microglial P2X7/CatS/FKN activated-pathway in antigen-induced arthritis of the temporomandibular joint of rats. Toxicon 2020; 187: 116–21. doi: 10.1016/j.toxicon.2020.08.027
Seyler TM, Jinnah RH, Koman LA, Marker DR, Mont MA, Ulrich SD, et al. Botulinum toxin type A injections for the management of flexion contractures following total knee arthroplasty. J Surg Orthop Adv 2008; 17(4): 231–8.
Jiang X, Jiang T, Qi X, Gai P, Sun H, Wang G. Methods of hamstring muscle injection of botulinum toxin type A combined with periarticular injection after total knee arthroplasty. STEMedicine 2023; 4(2): e171. doi: 10.37175/stemedicine.v4i2.171
Rosso F, Cottino U, Dettoni F, Bruzzone M, Bonasia DE, Rossi R. Revision total knee arthroplasty (TKA): mid-term outcomes and bone loss/quality evaluation and treatment. J Orthop Surg Res 2019; 14(1): 280. doi: 10.1186/s13018-019-1328-1
Duellman TJ, Gaffigan C, Milbrandt JC, Allan DG. Multi-modal, pre-emptive analgesia decreases the length of hospital stay following total joint arthroplasty. Orthopedics 2009; 32(3): 167. doi: 10.3928/01477447-20090301-08
Bellows S, Jankovic J. Reply to comment on re-visiting immunogenicity associated with botulinum toxin treatment. Toxins 2019, 11, 491. Toxins (Basel) 2020; 12(2): 71. doi: 10.3390/toxins12020072
Rezasoltani Z, Azizi S, Najafi S, Sanati E, Dadarkhah A, Abdorrazaghi F. Physical therapy, intra-articular dextrose prolotherapy, botulinum neurotoxin, and hyaluronic acid for knee osteoarthritis: randomized clinical trial. Int J Rehabil Res 2020; 43(3): 219–27. doi: 10.1097/MRR.0000000000000411
McAlindon TE, Schmidt U, Bugarin D, Abrams S, Geib T, DeGryse RE, et al. Efficacy and safety of single-dose onabotulinumtoxinA in the treatment of symptoms of osteoarthritis of the knee: results of a placebo-controlled, double-blind study. Osteoarthritis Cartilage 2018; 26(10): 1291–9. doi: 10.1016/j.joca.2018.05.001
Matak I. Evidence for central antispastic effect of botulinum toxin type A. Br J Pharmacol 2020; 177(1): 65–76. doi: 10.1111/bph.14846
Okamoto M, Atsuta Y. Cartilage degeneration is associated with augmented chemically-induced joint pain in rats: a pilot study. Clin Orthop Relat Res 2010; 468(5): 1423–7. doi: 10.1007/s11999-009-1193-z
Wu T, Song HX, Dong Y, Ye Y, Li JH. Intra-articular injections of botulinum toxin a for refractory joint pain: a systematic review and meta-analysis. Clin Rehabil 2017; 31(4): 435–43. doi: 10.1177/0269215516644951
Sethi N, Singh S, DeBoulle K, Rahman E. A review of complications due to the use of botulinum toxin A for cosmetic indications. Aesthetic Plast Surg 2021; 45(3): 1210–20. doi: 10.1007/s00266-020-01983-w
Copyright (c) 2023 Xiaofeng Jiang, TaoTao Jiang, Xiaojun Qi, Pengzhou Gai, Hongliang Sun, Guangda Wang
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain full copyright to their individual works, and publishing rights without restrictions.
In accordance with the Budapest Open Access Initiative, articles published in STEMedicine are freely available "on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself. The only constraint on reproduction and distribution, and the only role for copyright in this domain, should be to give authors control over the integrity of their work and the right to be properly acknowledged and cited."
Except where otherwise noted, all content on this website is licensed under a Creative Commons Attribution 4.0 License. This license allows for commercial and non-commercial redistribution as well as modifications of the work as long as attribution is given to the authors and STEMedicine as the original publication source, and a link to the article on the STEMedicine website is provided.